Navigation Links
Nastech Announces Third Quarter 2007 Financial Results
Date:10/29/2007

ion in restricted cash at each date. The increase in our cash balance was driven by the January 2007 offering of common stock which raised net proceeds of approximately $40.9 million.

Recent Corporate Highlights

* Initiated a Phase 2 clinical trial for PYY(3-36) Nasal Spray for

obesity

* Initiated a Phase 2 clinical trial for Insulin Nasal Spray for diabetes

* Announced promotion of Henry "Rick" Costantino to Chief Scientific

Officer of Delivery

Conference Call and Webcast Information

Management will host a conference call to review our financial results for the period ended September 30, 2007 and recent business developments. The call is scheduled for today, October 29, 2007, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). To participate in the live conference call, U.S. residents should dial (866) 831-6243 and international callers should dial (617) 213- 8855. The access code for the live conference call is 60453924. To access the 24-hour telephone replay, U.S. residents should dial (888) 286-8010 and international callers should dial (617) 801-6888. The access code for the replay is 53042322.

Alternatively, log on to http://www.nastech.com to access a live webcast or the subsequent archive. Please connect to the Investor section of Nastech's website several minutes prior to the start of the live conference call to ensure adequate time for any software download that may be necessary.

About Nastech

Nastech is a biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://ww
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/16/2009)... introduces HSP-A Soy Peptone. HSP A has been found to ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ... Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), ... improve growth rates and yields. HSP-A has been found to ...
(Date:12/15/2009)... Dec. 15 Epeius Biotechnologies Corporation, an ... medicine, gained international validation of the cutting-edge science ... when scientists around the world rediscovered the ... locus of cancer pathogenesis and disease progression, and ... scientists at the NIH National Cancer Institute investigating ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) today announced ... funding to support the ongoing development of new ... Association (MDA). This grant will support the ... manufacture of a drug candidate for human clinical ... provides important funding for Repligen,s research but it ...
Breaking Biology Technology:Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... German . , In this information age, ... and technology. A team of German and Italian researchers ... storage domains". As the scientists, led by Massimiliano Cavallini ... and Mario Ruben at the Forschungszentrum Karlsruhe (Germany), report ...
... Pa., Oct. 27 BioTrends Research Group, Inc.,released ... from 204 Nephrologists and 201 Renal Dietitians in ... of the management of dialysis,patients, particularly in their ... Vitamin D, and Calcimimetic agents., In the ...
... Jersey, October 27, Rosetta Genomics Ltd. (Nasdaq: ROSG ... and therapeutics, today,announced that Credit Suisse, as part ... Attorney General of the State of New York ... has begun to,repurchase Rosetta Genomics ARS. So far, ...
Other Biology Technology:Progress toward new storage media 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics 2Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics 3
(Date:12/15/2009)... The mouse is a standard laboratory model organism, ... conventional techniques to analyze blood and blood-forming tissues ... of compact and easy-to-use laboratory resources from Cold ... Mouse Hematology features step-by-step protocols for ... blood, bone marrow, and other hematopoietic tissues in ...
(Date:12/14/2009)... molecule in a freeze-tolerant Alaska beetle able to survive ... described biological antifreezes that contain protein, this new molecule, ... composed of a sugar and a fatty acid and ... organisms. , "The most exciting part of this ... kind of antifreeze that may work in a different ...
(Date:12/14/2009)... most comprehensive study to date of the proteins in ... provide important clues to how similar regeneration could be ... of Science at Indiana University-Purdue University Indianapolis and colleagues ... of axolotls, a type of salamander that has the ... of amputation, with the hope that this knowledge will ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 1CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 2CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 3CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 4The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 1The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 2Computers Causing Injuries in the Home 48275 1Computers Causing Injuries in the Home 48275 2Computers Causing Injuries in the Home 48275 3
... created technology to regrow teeth--the first time scientists have ... low-intensity pulsed ultrasound (LIPUS), Dr. Tarak El-Bialy from the ... and Dr. Ying Tsui from the Faculty of Engineering ... and novel way to stimulate jaw growth and dental ...
... be blocked by pain medications such as Advil and ... understood, a Queen's University study has found. , "The ... we classify the commonly used anti-inflammatory and pain drugs ... professor of Biochemistry and Physiology at Queen's and Canada ...
... Noel Dahl and Mohammad F. Islam have made a ... disease that accelerates the aging process by about seven ... of chemical and biomedical engineering at Carnegie Mellon, said ... of the National Institutes of Health (NIH), the John ...
Other Biology News:Ultrasound may help regrow teeth 2New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds 2Carnegie Mellon researchers discover new cell properties 2
... 48 lanes, 24 bi-directional, of patient DNA ... either slab gel or capillary sequencers, using ... parameters in Explorer have been sealed to ... have built Explorer for ease of use, ...
... Quality ISO 9001:2000 Certified USDA Research ... Validated, SOP's Training AALAS Certified ... All Procedures GLP Documentation Upon Request ... shopping point for all your custom immunology ...
...
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Biology Products: